Cargando…

Olfactory dysfunction during COVID-19 pandemic()

Detalles Bibliográficos
Autores principales:	Izquierdo-Domínguez, Adriana, Rojas-Lechuga, María Jesús, Mullol, Joaquim, Alobid, Isam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2020
Materias:	Special Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546227/ https://www.ncbi.nlm.nih.gov/pubmed/33072867 http://dx.doi.org/10.1016/j.medcle.2020.06.023

Ejemplares similares

Pérdida del sentido del olfato durante la pandemia COVID-19
por: Izquierdo-Domínguez, Adriana, et al.
Publicado: (2020)

Management of Allergic Diseases During COVID-19 Outbreak
por: Izquierdo-Domínguez, Adriana, et al.
Publicado: (2021)

Chemosensory dysfunction in COVID-19 out-patients
por: Rojas-Lechuga, María Jesús, et al.
Publicado: (2020)

Olfactory Dysfunction in Mental Illness
por: Marin, Concepció, et al.
Publicado: (2023)

Olfactory Dysfunction in a Mexican Population Outside of COVID-19 Pandemic: Prevalence and Associated Factors (the OLFAMEX Study)
por: Castillo-López, Irma Yolanda, et al.
Publicado: (2020)

The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries
por: Mullol, Joaquim, et al.
Publicado: (2020)

Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study)
por: Jaume, Francesca, et al.
Publicado: (2018)

Reply
por: Mullol, Joaquim, et al.
Publicado: (2020)

551 The Impact of Nasal Polyposis on Quality of Life Using the Eq-5d Health Profile
por: Alobid, Isam, et al.
Publicado: (2012)

Management of Mechanical Nasal Obstruction Isolated or Associated to Upper Airway Inflammatory Diseases in Real Life: Use of both Subjective and Objective Criteria
por: Merma-Linares, Carla, et al.
Publicado: (2023)

133 Corticosteroid Rreatment Reduces Tissue Eosinophilia and the Expression of Matrix Metalloproteinases (MMP-1, MMP-2, MMP-7, MMP-9) and Their Tissue Inhibitor (TIMP-1) in Nasal Polyps
por: de Borja Callejas, Fco, et al.
Publicado: (2012)

Consensus on the management of united airways disease with type 2 inflammation: a multidisciplinary Delphi study
por: Blanco-Aparicio, Marina, et al.
Publicado: (2023)

Signal Transduction Pathways (MAPKs, NF-κB, and C/EBP) Regulating COX-2 Expression in Nasal Fibroblasts from Asthma Patients with Aspirin Intolerance
por: Garcia-Garcia, Francesc Josep, et al.
Publicado: (2012)

Effect of Lipopolysaccharide on Glucocorticoid Receptor Function in Control Nasal Mucosa Fibroblasts and in Fibroblasts from Patients with Chronic Rhinosinusitis with Nasal Polyps and Asthma
por: Fernández-Bertolín, Laura, et al.
Publicado: (2015)

Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study
por: Inciarte, Alexy, et al.
Publicado: (2021)

Reconstituted Human Upper Airway Epithelium as 3-D In Vitro Model for Nasal Polyposis
por: de Borja Callejas, Francisco, et al.
Publicado: (2014)

The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice
por: Desai, Mauli, et al.
Publicado: (2021)

Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study)
por: Mullol, Joaquim, et al.
Publicado: (2012)

Superior effect of MP‐AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP‐1 and TTP anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa
por: Vicens‐Artés, Sònia, et al.
Publicado: (2022)

Effect of MP‐AzeFlu compared to monotherapy on COX‐2, PGE(2), and EP2 gene expression in upper airway mucosa
por: Vicens‐Artes, Sonia, et al.
Publicado: (2022)

Self-reported Taste and Smell Disorders in Patients with COVID-19: Distinct Features in China
por: Song, Jia, et al.
Publicado: (2021)

Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic
por: Kusnik, Alexander, et al.
Publicado: (2021)

Olfactory and Gustatory Dysfunction as an Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study
por: Qiu, Chenghao, et al.
Publicado: (2020)

Olfactory dysfunction and COVID-19
por: Wan, Yi-Min, et al.
Publicado: (2020)

Olfactory dysfunction and COVID-19
por: Choi, Rhea, et al.
Publicado: (2022)

Mometasone and desloratadine additive effect on eosinophil survival and cytokine secretion from epithelial cells
por: Mullol, Joaquim, et al.
Publicado: (2011)

Olfactory Dysfunction in Frontline Health Care Professionals During COVID-19 Pandemic in Brazil
por: Sbrana, Mariana Ferreira, et al.
Publicado: (2021)

Chemosensory Dysfunction in Patients with COVID-19: What Do We Learn from the Global Outbreak?
por: Zeng, Ming, et al.
Publicado: (2021)

Comparative Analysis of Olfactory and Gustatory Function of Patients With COVID-19 Olfactory Dysfunction and Non-COVID-19 Postinfectious Olfactory Dysfunction
por: Jung, Taesik, et al.
Publicado: (2023)

Olfactory dysfunction in the scenario of COVID-19 pandemic in patients screened by the telemonitoring
por: Valletta, Raíssa Camelo, et al.
Publicado: (2021)

Olfactory Dysfunction in COVID-19 Detection
Publicado: (2021)

Cardiovascular considerations for anesthesiologists during the COVID-19 pandemic
por: Hirata, Naoyuki, et al.
Publicado: (2020)

Olfactory Dysfunction following COVID-19 and the Potential Benefits of Olfactory Training
por: Alarfaj, Abdullah A., et al.
Publicado: (2023)

Use of lung ultrasound in neonates during the COVID-19 pandemic
por: Matsuoka, Marcia Wang, et al.
Publicado: (2020)

Using Telemedicine During the COVID-19 Pandemic
por: Mahajan, Vidushi, et al.
Publicado: (2020)

Olfactory Dysfunction in COVID-19, a Review of the Evidence and Implications for Pandemic Management()
por: Lop Gros, Joan, et al.
Publicado: (2020)

Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers
por: Roca-Ferrer, Jordi, et al.
Publicado: (2018)

Protection of nephrology health professionals during the COVID-19 pandemic()
por: Arenas, María Dolores, et al.
Publicado: (2020)

Temporal Profile of Olfactory Dysfunction in COVID-19
por: Loftus, Patricia A., et al.
Publicado: (2020)

Management of post-COVID-19 olfactory dysfunction
por: Wu, Tara J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ca78dr0c9jpq0q0fhffqdi3843